FIELD: biotechnology.
SUBSTANCE: invention relates to organic chemistry, namely to a new heterocyclic compound [RD93], which may be useful for treatment of hormone-refractory prostate cancer, benign prostatic hyperplasia, breast cancer and ovarian cancer.
EFFECT: new heterocyclic compound with useful biological properties is obtained.
6 cl, 41 dwg, 11 tbl, 61 ex
Title | Year | Author | Number |
---|---|---|---|
DIARYLHYDANTOINS | 2021 |
|
RU2828689C2 |
DIARYL-SPIROHYDANTOIC COMPOUNDS USEFUL IN HYPERPOLIFERATIVE DISORDER TREATMENT | 2012 |
|
RU2668972C2 |
DIARYLTHIOHYDATOIC COMPOUNDS | 2007 |
|
RU2449993C2 |
METHODS OF FORMING GLYCOSIDE BONDS, CHEMICAL COMPOSITION, GLYCOSIDE AND GLYCOSIDE LIBRARY | 1994 |
|
RU2134693C1 |
COMPOUNDS USEFUL AS TRPM8 MODULATORS | 2011 |
|
RU2608109C2 |
METHOD FOR REDUCING OF BROKEN OPYOID RECEPTOR FUNCTIONS | 1996 |
|
RU2307833C2 |
VITAMIN D ANALOGS, METHODS OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2153491C2 |
DERIVATIVES OF PIPERAZINE AND PIPERIDINE AND PHARMACEUTICAL COMPOSITION | 1996 |
|
RU2194702C2 |
BENZO-DERIVATIVES WITH SIX-MEMBERED RING AS DPP-4 INHIBITOR AND USE THEREOF | 2015 |
|
RU2702644C2 |
BIPHENYL DERIVATIVES HAVING BIOLOGICAL ACTIVITY, PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATMENT BASED ON SAID COMPOUNDS AND USE THEREOF | 2020 |
|
RU2736511C1 |
Authors
Dates
2017-12-18—Published
2011-12-23—Filed